Does SONIDEGIB Cause Therapy cessation? 64 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Therapy cessation have been filed in association with SONIDEGIB (Odomzo). This represents 4.5% of all adverse event reports for SONIDEGIB.
64
Reports of Therapy cessation with SONIDEGIB
4.5%
of all SONIDEGIB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Therapy cessation From SONIDEGIB?
Of the 64 reports, 1 (1.6%) resulted in death, 2 (3.1%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SONIDEGIB. However, 64 reports have been filed with the FAERS database.
What Other Side Effects Does SONIDEGIB Cause?
Muscle spasms (182)
Alopecia (107)
Off label use (100)
Fatigue (94)
Death (87)
Product use issue (70)
Nausea (69)
Product dose omission issue (66)
Ageusia (59)
Asthenia (59)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which SONIDEGIB Alternatives Have Lower Therapy cessation Risk?
SONIDEGIB vs SORAFENIB
SONIDEGIB vs SORGHUM HALEPENSE POLLEN
SONIDEGIB vs SOTAGLIFLOZIN
SONIDEGIB vs SOTALOL
SONIDEGIB vs SOTATERCEPT